ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,525Medicare Part D Prescriptions Filled, Including Refills

Rank: 240 out of 783

$473K Total Retail Price of All Prescriptions

Rank: 291 out of 783

357 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 357 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 357 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 7,548 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 398 342 1 3
HYDROCODONE-ACETAMINOPHEN 319 254 S3 2 2
OMEPRAZOLE 310 253 3 6
WARFARIN SODIUM 310 297 3 10
LEVOTHYROXINE SODIUM 289 236 5 1
AMLODIPINE BESYLATE 278 262 6 5
LISINOPRIL 271 243 7 4
FUROSEMIDE 229 216 8 7
POTASSIUM CHLORIDE 229 219 8 16
NAMENDA 213 213 10 32
METOPROLOL TARTRATE 153 141 11 9
DONEPEZIL HCL 152 152 12 24
HYDROCHLOROTHIAZIDE 152 123 12 12
TRAMADOL HCL 135 117 14 20
GABAPENTIN 130 115 15 15
METFORMIN HCL 115 106 16 8
CITALOPRAM HBR 114 114 17 19
METOPROLOL SUCCINATE 98 91 18 13
TAMSULOSIN HCL 93 91 19 26
MIRTAZAPINE 92 80 20 52
PLAVIX 80 78 21 51
FAMOTIDINE 77 70 22 55
ATENOLOL 75 56 23 17
CARVEDILOL 74 74 24 21
DIOVAN 74 74 24 49
CRESTOR 74 70 24 27
GLIPIZIDE 70 54 27 71
LANTUS 70 63 27 38
ESCITALOPRAM OXALATE 67 66 29 54
CLOPIDOGREL 66 65 30 29
DIGOXIN 65 65 31 61
LIDODERM 64 64 32 132
SINGULAIR 63 50 33 90
CYMBALTA 61 48 34 35
QUETIAPINE FUMARATE 60 60 35 79
ADVAIR DISKUS 60 51 35 50
PAROXETINE HCL 59 39 37 69
SERTRALINE HCL 59 47 37 22
PROAIR HFA 55 41 39 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.